SCHEMBL5717036

SCHEMBL5717036

CC1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.74

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.74
PSEN1 P49768 1/20 0.68
PSEN2 P49810 1/20 0.68
APH1B Q8WW43 1/20 0.68
NCSTN Q92542 1/20 0.68
APH1A Q96BI3 1/20 0.68
PSENEN Q9NZ42 1/20 0.68
AKR1C3 P42330 8/20 0.60
LMNA P02545 2/20 0.59
KMT2A Q03164 3/20 0.56
ALDH1A1 P00352 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 2/20 0.52
USP2 O75604 1/20 0.52
MAPT P10636 1/20 0.52
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11959875 0.85 HSD11B1 (1.00) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL13036462 0.85 HSD11B1 (1.00) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL11959849 0.85 HSD11B1 (1.00) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL26079698 0.84 BRD4 (0.73) HSD11B1AKR1C3KMT2AALDH1A1MEN1
SCHEMBL23806103 0.84 BRD4 (0.73) HSD11B1AKR1C3KMT2AALDH1A1MEN1
SCHEMBL2305949 0.84 HSD11B1 (0.58) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL14298935 0.82 ACHE (0.68) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL12169388 0.82 ACHE (0.68) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL5717132 0.82 PSEN1 (0.70) HSD11B1PSEN1PSEN2APH1BNCSTN
SCHEMBL3116741 0.82 PSEN1 (0.75) HSD11B1PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed